In COVID-19 clinical update #49, Daniel Griffin discusses CDC guidelines on mask use, drop in test frequency in the US, resurgence of COVID-19 in Brazil, possible impact of Pfizer vaccine on viral load, EUA for bamlanivimab and etesevimab administered together, and preliminary results of Tocilizumab in hospitalized patients.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Resurgence of COVID-19 in Brazil (Lancet)
• Pfizer vaccine reduces viral load (medRxiv)
• EUA for bamlanivimab plus etesevimab (pdf)
• Tocilizumab in hospitalized patients (medRxiv)
• Bacterial superinfections in COVID-19 (Open For Inf Dis)
• Letters read on TWiV 719
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]